Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT04868916
Ignite Creation Date: 2024-05-06 @ 4:05 PM
Last Modification Date: 2025-12-16 @ 10:10 PM
Study NCT ID: NCT04868916
Protocol Section: NCT04868916
Start Identification Module Data
Expand Identification Module Data
Brief Title: An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
Official Title: Prospective Observational Study to Estimate the Genotype and Phenotype of Japanese Patients With X-linked Retinitis Pigmentosa Associated With Pathogenic Variants in Retinitis Pigmentosa GTPase Regulator (RPGR)
Acronym: None
Organization: Janssen Pharmaceutical K.K.
Organization Class: INDUSTRY
Organization Study ID: CR108926
Secondary IDs
Secondary ID Type Domain Link
74765340RPG0001 OTHER Janssen Pharmaceutical KK Japan None
Start Status Module Data
Status Verified Date: 2025-04
Overall Status: None
Study First Submit Date: 2021-04-28
Study First Submit QC Date:
Last Update Submit Date: 2025-04-24
Status: COMPLETED
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Janssen Pharmaceutical KK
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Janssen Pharmaceutical KK
Start Oversight Module Data 371925
Description Module: 375425
Study Last Update Post Date Type(Status Module):
Attachment: Upload